These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-004840-30 ADJUVANT CHEMOTHERAPY WITH PEMETREXED AND CISPLATIN vs. VINORELBINE AND CISPLATIN IN NSCLC IB, IIA, IIB, T3N1: A RANDOMIZED PHASE II STUDY 2014-04-14 due-trials
Reported results Terminated 2013-001613-33 Iloprost for Bridging to Heart Transplantation in Patients with Pulmonary Hypertension and Left Heart Failure 2015-03-17 due-trials
Reported results 2014-001882-28 Early Treatment of Borderline Pulmonary Arterial Hypertension Associated with Systemic Sclerosis (SSc-APAH) Frühe Behandlung von grenzwertig erhöhten Lungendrucken bei Patienten mit Sklerodermie/sy... 2017-11-27 due-trials
Completed, but no date 2018-001387-39 A prospective, randomized, controlled trial to assess the effect of long-term oxygen therapy on 6-minute walking distance, clinical parameters and hemodynamics in patients with pulmonary arterial hype... bad-data
Other 2020-005462-34 An open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension ... not-yet-due
Other 2021-001633-40 Efficacy and safety of riociguat (MK-4836) in incipient pulmonary vascular disease as an indicator for early pulmonary arterial Hypertension Doubleblind, randomized, multicentre, multinational, placeb... not-yet-due